The U.S. Supreme Court is scheduled to hear arguments this morning in a case that could end cy pres, the practice of steering money in class action settlements to organizations with absolutely no connection to the underlying lawsuit. Proponents say cy pres – it translates roughly into “as good as” Read more…
Lawsuits against distributors, pharmacies will rely on `aggregate proof’ too many pills were sold, without any examples of improper prescriptions to show how it happened. My latest story for Legal Newsline on Forbes: Plaintiffs in bellwether trials against the opioid industry scheduled to begin next year will try to prove Read more…
As published on Legal Newsline: BOSTON (Legal Newsline) – The federal judge who unleashed a wide-ranging investigation into the fee practices of Labaton Sucharow was unimpressed by the class action firm’s agreement to install an ethics monitor and revamp its rules, saying he was more concerned about getting to the Read more…
As reported by Legal Newsline on Forbes.com: A settlement binding all potential plaintiffs may be the only practical way of ending nearly 2,000 lawsuits against manufacturers, distributors and retailers of addictive opioid painkillers, said plaintiff lawyers attending a conference on opioid litigation this week. Some 1,200 lawsuits are gathered in Read more…